Home Lecheng Cloud Services Completes Pre-A Funding Round Led by Danlu Capital to Accelerate Integrated 'Pharma-Health-Commerce-Insurance' Platform

Lecheng Cloud Services Completes Pre-A Funding Round Led by Danlu Capital to Accelerate Integrated 'Pharma-Health-Commerce-Insurance' Platform

Dec 14, 2021 08:00 CST Updated 08:00
Shenzhen Xiaobu Running Technology Group

Internet Insurance Technology Service Provider

VCBeat has learned that recently,Shenzhen Xiaobu Running Technology Group (hereinafter referred to as “Lecheng Yunfu”) announced the completion of its Pre-A financing round, led by Danlu Capital and followed by investments from prominent individual industry investors.It is reported that the funds from this round of financing will be used to accelerate the company’s team building, increase investment in scientific research, and promote the development and implementation of digital models by Shenzhen Xiaobu Running Technology Group. The company aims to create more competitive integrated healthcare, pharmaceutical, and insurance protection products and services, thereby continuously supporting the high-quality development of the industry.

微信图片_20211213161904.jpg

 

Deep Integration and Innovation in Insurance and Holistic Health; Xiaobu Running Technology Steadily Accelerates


As a company established less than a year ago, Shenzhen Xiaobu Running Technology Group adheres to the “five-in-one” strategy integrating pharmaceuticals, healthcare, health management, commerce, and insurance. It has not only made significant strides in the deep customization of commercial insurance by collaborating with major insurers to launch exclusive, best-selling customized products, but also integrated diverse medical resources and products under its Leyitong platform into insurance product development and design, user interaction experiences, comprehensive claims management, and insurer risk control services. Targeting the closed loop of medical services and health management for insurance customers, Shenzhen Xiaobu Running Technology Group has engaged in in-depth cooperation with multiple insurance institutions and independent agents, taking substantial steps toward the deep integration of healthy medical lifestyles and insurance.


Shenzhen Xiaobu Running Technology Group has introduced a comprehensive solution integrating insurance and health services. Leveraging its underlying SaaS infrastructure, the company connects reinsurers, insurers, and health service providers through open APIs, jointly establishing digital research models for product design and pricing strategies.

First, it meets consumers’ diversified needs through liability coverage and service innovation. Second, it provides a foundation for product pricing and business risk control. By integrating the five-in-one strategy of “pharmaceuticals, medical care, health management, commerce, and insurance,” it forms an ecosystem-based matrix of insurance products. The accumulation of health data within the technology middle platform creates barriers in product design. Meanwhile, a multi-channel intelligent risk control system helps insurers strictly maintain the quality of business across multiple channels.


In the more than six months since its establishment, Shenzhen Xiaobu Running Technology Group has achieved steady and rapid growth in both business operations and capital markets. Through product innovation and operational excellence, it has successively launched several best-selling products, including Orange Guardian No. 1 Critical Illness Insurance, Ping An Orange Protector Accident Insurance, Aixin Leyangduo Pension Annuity Insurance, and Le Manman Increasing Whole Life Insurance. Products under the “Xiaobu Running” brand have quickly risen to the top of the market in terms of single-product sales, with monthly sales figures repeatedly doubling. In the capital market, Shenzhen Xiaobu Running Technology Group completed its Pre-A financing round in a short period, led by Danlu Capital, a professional healthcare investment institution.

 

Dual Advantages of Innovation and Experience: Xiaobu’s Journey Is Both a Sprint and a Marathon


Liang Yucheng, Project Lead at Redhill Capital“Just as a journey of a thousand miles begins with a single step, Lecheng Cloud Services remains committed to its foundational mission of providing safeguards. By bringing together serial entrepreneurs from the insurance, internet, and healthcare sectors, we are optimistic about the company’s deep collaboration with insurance and healthcare enterprises. We believe that, empowered by the team’s comprehensive and extensive experience, the company will inject greater vitality into the development of commercial insurance. Within just six months, Lecheng Cloud Services’ innovative explorations at the intersection of health, medical care, lifestyle, and insurance have already begun to yield results. We look forward to the company’s integrated ‘Pharmaceutical-Healthcare-Commercial Insurance’ platform addressing more supply-demand imbalances and delivering enhanced health protection to consumers.”


Xu Han, Founder and CEO of Shenzhen Xiaobu Running Technology GroupHe stated, “While internet insurance has experienced rapid growth, insurance products have become increasingly homogeneous. Some products have strayed from their original mission, no longer focusing on consumers’ genuine needs. We aim to explore a path of deep integration between insurance and health-medical lifestyles, leveraging technology to refocus products on health protection and make high-quality health services more accessible. We sincerely appreciate the recognition and trust of the investors in this round. With the concerted cooperation and support of our investors and partners across the industry chain, we hope to stay true to our original aspiration and advance steadily with ‘small steps.’”

>>>>

About Redhill Capital


Redhill Capital focuses on early-stage investments in innovative medical technology companies. Its core management and investment team hail from renowned domestic venture capital fund management firms. Founding partners Lu Qinchao and Su Zhenbo each possess nearly two decades of experience in the healthcare industry and investment. Redhill Capital currently manages multiple RMB-denominated funds and one USD-denominated fund, with investors including prominent market-oriented funds of funds, asset management companies, government guidance funds, industrial capital, family offices, and well-known publicly listed companies.